Skip to main content

Steven J. Yakubov, MD

08/01/2008
Treatment options for bypass graft disease, such as repeat CABG and percutaneous revascularization, are limited and provide disappointing outcomes.1-4 Patients undergoing repeat CABG have over a four times greater rate of mortality compared...
Treatment options for bypass graft disease, such as repeat CABG and percutaneous revascularization, are limited and provide disappointing outcomes.1-4 Patients undergoing repeat CABG have over a four times greater rate of mortality compared...
Treatment options for bypass...
08/01/2008
Journal of Invasive Cardiology
06/19/2008
Recently, there has been an increased focus in the field of interventional cardiology on proper techniques. What has sparked renewed interest on this topic? When drug-eluting stents (DES) were first introduced, restenosis rates were so low...
Recently, there has been an increased focus in the field of interventional cardiology on proper techniques. What has sparked renewed interest on this topic? When drug-eluting stents (DES) were first introduced, restenosis rates were so low...
Recently, there has been an...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Recently, there has been an increased focus in the field of interventional cardiology on proper techniques. What has sparked renewed interest on this topic? When drug-eluting stents (DES) were first introduced, restenosis rates were so low...
Recently, there has been an increased focus in the field of interventional cardiology on proper techniques. What has sparked renewed interest on this topic? When drug-eluting stents (DES) were first introduced, restenosis rates were so low...
Recently, there has been an...
06/19/2008
Cath Lab Digest
Original Contribution
08/01/2008
Approximately 1 million patients are now treated annually in the United States with drug-eluting stents (DES). Usage of these stents is substantiated in many patient and lesion subsets by their documented relative safety and reduction in...
Approximately 1 million patients are now treated annually in the United States with drug-eluting stents (DES). Usage of these stents is substantiated in many patient and lesion subsets by their documented relative safety and reduction in...
Approximately 1 million patients...
08/01/2008
Journal of Invasive Cardiology